# Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone

> **NCT01806363** · PHASE1 · COMPLETED · sponsor: **HanAll BioPharma Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan 80mg
- **DRUG:** Chlorthalidone 25mg

## Key facts

- **NCT ID:** NCT01806363
- **Lead sponsor:** HanAll BioPharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01806363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01806363, "Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01806363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*